Givaudan stock: UBS lifts target for Givaudan stock to CHF 3,960.00

Published on 10/20/2026 at 17:27 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Sales hit CHF 5.89 billion for nine months on October 13, 2026. Givaudan stock costs EUR 4,261.50 on October 20, 2026, 0.05 percent above Frankfurt close.

Analyst target and sales

UBS lifted its Givaudan target from CHF 3,270.00 to CHF 3,960.00 on October 15, 2026.
Givaudan reported CHF 5.89 billion in nine-month sales on October 13, 2026.
Givaudan stock costs EUR 4,261.50 at Lang & Schwarz on October 20, 2026 at 5:12 p.m. CEST, 0.05 percent above the Frankfurt close of October 19, 2026.
Givaudan will hold an investor presentation on October 29, 2026.

A pop art comic book illustration of a stylised perfume bottle. The unlabelled pink geometric bottle sits at the centre, emanating large swirling fragrance clouds in hot pink and aqua with halftone Ben-Day dot patterns. A yellow sunburst fills the backgro — Givaudan CH0010645932 Pop-Art-Parfumflakon mit Halftone-Punkten, pinken und türkisen Comic-Duftwolken auf gelbem Hintergrund, Illustration mit AI erstellt.

UBS raised its Givaudan price target from CHF 3,270.00 to CHF 3,960.00 on October 15, 2026, while retaining a Neutral rating, according to FinanzNachrichten. The target was 0.13 percent above Givaudan's CHF 3,955.00 SIX price at 5:09 p.m. CEST on October 20, 2026. At Lang & Schwarz, the stock stood at EUR 4,261.50 on October 20, 2026 at 5:12 p.m. CEST, up 0.05 percent versus the Frankfurt close of October 19, 2026 at EUR 4,259.50.

Sales reach CHF 5.89 billion

Givaudan reported sales of CHF 5,891 million for the first nine months of 2026, with like-for-like growth of 8.60 percent in the third quarter. The company had published the nine-month update on October 13, 2026, according to its investor page.

The latest company figures show the contrast behind the analyst debate. Full-year 2025 sales were CHF 7,472 million, up 5.10 percent on a like-for-like basis, while EBITDA reached CHF 1,751 million with a 23.40 percent margin. These historical figures provide a profitability benchmark for the 2026 sales momentum.

Analysts disagree on valuation

UBS's target sits close to the SIX price, but other recent research points to a wider range. Deutsche Bank raised its target from CHF 3,700.00 to CHF 4,100.00 and kept a Buy rating on October 14, 2026, according to MarketScreener. Bernstein raised its target from CHF 2,886.00 to CHF 3,004.00 but maintained Underperform on October 13, 2026, as reported by finanzen.at.

Investor presentation is October 29

Givaudan's next listed investor event is scheduled for October 29, 2026, with a presentation in Zurich at 3:00 p.m. CET. The company also lists year-end results for January 26, 2027 in its financial calendar. Its market capitalization was CHF 36.5 billion on October 20, 2026, and the 52-week SIX range was CHF 2,566.00 to CHF 3,985.00.

Stock valuation stays near the target

The 29.37 price-to-earnings ratio and 2.00 percent dividend yield frame the current valuation, while the CHF 3,960.00 UBS target is only 0.13 percent above the SIX price. The spread between Bernstein's CHF 3,004.00 target and Deutsche Bank's CHF 4,100.00 target leaves investors with a wide range of published expectations.

The further course of trading is shown by the continuously updated real-time quote of Givaudan stock.